NCT03740334 2025-11-21
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Dana-Farber Cancer Institute
Phase 1 Active not recruiting
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × ribociclib × Other hematologic neoplasm × Clear all